JP2024513003A5 - - Google Patents
Info
- Publication number
- JP2024513003A5 JP2024513003A5 JP2023559849A JP2023559849A JP2024513003A5 JP 2024513003 A5 JP2024513003 A5 JP 2024513003A5 JP 2023559849 A JP2023559849 A JP 2023559849A JP 2023559849 A JP2023559849 A JP 2023559849A JP 2024513003 A5 JP2024513003 A5 JP 2024513003A5
- Authority
- JP
- Japan
- Prior art keywords
- csf1r
- modified
- nucleic acid
- recombinant nucleic
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169578P | 2021-04-01 | 2021-04-01 | |
| US63/169,578 | 2021-04-01 | ||
| US202163236951P | 2021-08-25 | 2021-08-25 | |
| US63/236,951 | 2021-08-25 | ||
| PCT/US2022/023139 WO2022212897A1 (en) | 2021-04-01 | 2022-04-01 | Genetic modification of mammalian cells to confer resistance to csf1r antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513003A JP2024513003A (ja) | 2024-03-21 |
| JP2024513003A5 true JP2024513003A5 (cg-RX-API-DMAC7.html) | 2025-04-03 |
Family
ID=83456857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559849A Pending JP2024513003A (ja) | 2021-04-01 | 2022-04-01 | Csf1rアンタゴニストに対する耐性を付与するための哺乳動物細胞の遺伝子改変 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20230248775A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4314003A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024513003A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022252407A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3215311A1 (cg-RX-API-DMAC7.html) |
| DE (4) | DE202022003132U1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2612467B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022212897A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12612599B2 (en) | 2018-09-10 | 2026-04-28 | Savanna Biotherapeutics, Inc. | Compositions and methods for microglia replacement therapy |
| DE202022003132U1 (de) * | 2021-04-01 | 2025-02-17 | The Regents Of The University Of California | Genetische Modifikation von Säugerzellen zur Verleihung von Resistenz gegen CSF1R-Antagonisten |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1576139A4 (en) * | 2002-11-26 | 2007-06-20 | Cold Spring Harbor Lab | INTERACTIVE PROTEINS AND ASSOCIATED METHODS OF DEP-1 RECEPTOR PROTEIN-TYROSINE PHOSPHATASE |
| US9044503B2 (en) | 2004-08-27 | 2015-06-02 | University Of Kentucky Research Foundation | Amyloid peptide inactivating enzyme to treat alzheimer's disease peripherally |
| WO2006069203A2 (en) | 2004-12-22 | 2006-06-29 | California Institute Of Technology | Methods for proteomic profiling using non-natural amino acids |
| WO2009089635A1 (en) | 2008-01-16 | 2009-07-23 | Neurodyn, Inc. | Treating neurodegenerative diseases with progranulin (pgrn) |
| KR20100054711A (ko) | 2008-11-14 | 2010-05-25 | 메디포스트(주) | 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물 |
| EP2424976B1 (en) | 2009-04-28 | 2013-07-31 | Life & Brain GmbH | Method for obtaining human microglial precursor cells from pluripotent stem cells |
| US8765117B2 (en) | 2009-06-10 | 2014-07-01 | The General Hospital Corporation | Generation of vascularized human heart tissue and uses thereof |
| CA2818253A1 (en) | 2010-11-16 | 2012-05-24 | Denis G. Kay | Method for increasing neprilysin expression and activity |
| CA2831609C (en) | 2011-03-30 | 2019-06-11 | Cellular Dynamics International, Inc. | Priming of pluripotent stem cells for neural differentiation |
| EP3092305B1 (en) | 2014-01-09 | 2023-08-02 | Kyushu University, National University Corporation | Method of producing microglial cells |
| US10081792B2 (en) | 2014-12-31 | 2018-09-25 | Wisconsin Alumni Research Foundation | Derivation of human microglia from pluripotent stem cells |
| CA2972598C (en) | 2014-12-31 | 2024-03-12 | Wisconsin Alumni Research Foundation | Human pluripotent stem cell-based models for predictive developmental neural toxicity |
| JP6774952B2 (ja) | 2015-01-16 | 2020-10-28 | エージェンシー フォー サイエンス, テクノロジー アンド リサーチ | 多能性幹細胞のマクロファージへの分化 |
| US10626372B1 (en) | 2015-01-26 | 2020-04-21 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| WO2016210313A1 (en) | 2015-06-24 | 2016-12-29 | Whitehead Institute For Biomedical Research | Culture medium for generating microglia from pluripotent stem cells and related methods |
| CA3016575A1 (en) | 2016-03-03 | 2017-09-08 | New York Stem Cell Foundation, Inc. | Microglia derived from pluripotent stem cells and methods of making and using the same |
| WO2017223199A1 (en) | 2016-06-22 | 2017-12-28 | Xcell Biosciences, Inc. | Methods for increasing cell culture transfection efficiency and cellular reprogramming |
| CN109963940A (zh) | 2016-09-02 | 2019-07-02 | 宝生物工程株式会社 | 从多能干细胞获得小胶质细胞的方法 |
| CA3038690A1 (en) | 2016-10-05 | 2018-04-12 | FUJIFILM Cellular Dynamics, Inc. | Generating mature lineages from induced pluripotent stem cells with mecp2 disruption |
| CN110621774A (zh) | 2016-10-14 | 2019-12-27 | 儿童医疗中心有限公司 | 用于治疗中枢神经系统疾病和病症的组合物和方法 |
| WO2018160496A1 (en) | 2017-02-28 | 2018-09-07 | The Regents Of The University Of California | Differentiation and use of human microglia-like cells from pluripotent stem cells and hematopoietic progenitors |
| WO2019118951A2 (en) | 2017-12-15 | 2019-06-20 | Duke University | Compositions and methods of enhancing the homing and/or engraftment of hematopoietic cells in the central nervous system |
| US12171764B2 (en) * | 2018-06-20 | 2024-12-24 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor |
| WO2020033791A1 (en) * | 2018-08-09 | 2020-02-13 | Verseau Therapeutics, Inc. | Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereof |
| US12612599B2 (en) * | 2018-09-10 | 2026-04-28 | Savanna Biotherapeutics, Inc. | Compositions and methods for microglia replacement therapy |
| CN113166219A (zh) | 2018-09-28 | 2021-07-23 | 纪念斯隆-凯特琳癌症中心 | 干细胞衍生的人小神经胶质细胞、制备方法及使用方法 |
| US12419915B2 (en) | 2019-03-13 | 2025-09-23 | The Broad Institute, Inc. | Microglial progenitors for regeneration of functional microglia in the central nervous system and therapeutics uses thereof |
| WO2020232512A1 (en) | 2019-05-22 | 2020-11-26 | The Council Of The Queensland Institute Of Medical Research | Microglial cells and methods of use thereof |
| WO2020252477A1 (en) | 2019-06-14 | 2020-12-17 | FUJIFILM Cellular Dynamics, Inc. | Methods for the production of multiple lineages from induced pluripotent stem cells using charged surfaces |
| EP4010361A4 (en) | 2019-08-06 | 2023-08-09 | Children's Medical Center Corporation | METHODS AND COMPOSITIONS FOR RESTORING MICROGLIA |
| TWI799733B (zh) | 2019-08-26 | 2023-04-21 | 臺北榮民總醫院 | 一種從體細胞製備誘導性多能幹細胞之方法 |
| WO2021221879A1 (en) | 2020-05-01 | 2021-11-04 | Albert Einstein College Of Medicine | Compositions and methods for using transplanted microglia as a vehicle for widespread delivery of cells and other biologic agents to the brain |
| US20240117431A1 (en) | 2020-06-02 | 2024-04-11 | The Regents Of The University Of California | Stem-cell based biomarker discovery |
| GB202011871D0 (en) | 2020-07-30 | 2020-09-16 | Cambridge Entpr Ltd | Composition and method |
| EP4204544A4 (en) | 2020-08-25 | 2024-10-30 | University Health Network | COMPOSITIONS AND METHODS FOR GENERATING HUMAN YOLK SAC-TYPE HEMATOPOIETIC CELLS |
| DE202022003132U1 (de) | 2021-04-01 | 2025-02-17 | The Regents Of The University Of California | Genetische Modifikation von Säugerzellen zur Verleihung von Resistenz gegen CSF1R-Antagonisten |
-
2022
- 2022-04-01 DE DE202022003132.7U patent/DE202022003132U1/de active Active
- 2022-04-01 DE DE202022002866.0U patent/DE202022002866U1/de active Active
- 2022-04-01 AU AU2022252407A patent/AU2022252407A1/en active Pending
- 2022-04-01 EP EP22782325.9A patent/EP4314003A4/en active Pending
- 2022-04-01 CA CA3215311A patent/CA3215311A1/en active Pending
- 2022-04-01 DE DE112022000079.1T patent/DE112022000079T5/de not_active Withdrawn
- 2022-04-01 WO PCT/US2022/023139 patent/WO2022212897A1/en not_active Ceased
- 2022-04-01 JP JP2023559849A patent/JP2024513003A/ja active Pending
- 2022-04-01 GB GB2219686.9A patent/GB2612467B/en active Active
- 2022-04-01 DE DE202022003066.5U patent/DE202022003066U1/de not_active Withdrawn - After Issue
- 2022-12-21 US US18/069,631 patent/US20230248775A1/en not_active Abandoned
- 2022-12-21 US US18/069,543 patent/US12421517B2/en active Active
-
2024
- 2024-06-11 US US18/739,622 patent/US20250002920A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ubeda et al. | Stress-induced binding of the transcription factor CHOP to a novel DNA control element | |
| Kurschner et al. | CIPP, a novel multivalent PDZ domain protein, selectively interacts with Kir4. 0 family members, NMDA receptor subunits, neurexins, and neuroligins | |
| Meurs et al. | Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon | |
| Inoue et al. | IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family | |
| Mogensen et al. | The type I interferon receptor: structure, function, and evolution of a family business | |
| Horvath et al. | Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex | |
| Shuai | Interferon-activated signal transduction to the nucleus | |
| Dingwall et al. | A family of Ran binding proteins that includes nucleoporins. | |
| US9746475B2 (en) | Antibody and antibody mimetic for visualization and ablation of endogenous proteins | |
| Posern et al. | Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G | |
| CN115850387B (zh) | 超高亲和力的靶向pd-l1的小蛋白及药物组合物 | |
| EP3481858A1 (en) | Modified ligand-gated ion channels and methods of use | |
| US6338949B1 (en) | Nucleic acids encoding receptor recognition factor stat4 and methods of use thereof | |
| JP2653653B2 (ja) | インターフエロン誘起遺伝子及び酵素 | |
| Qin et al. | Leader RNA regulates snakehead vesiculovirus replication via interacting with viral nucleoprotein | |
| Hara et al. | A small fragmented P protein of respiratory syncytial virus inhibits virus infection by targeting P protein | |
| CN107034201B (zh) | 表观修饰酶setd2的抗病毒作用及其应用 | |
| Dunbar et al. | Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: identity with subunit 2 of the 26S protease | |
| EP0720652A1 (en) | Receptor recognition factors, protein sequences and methods of use thereof | |
| CA2132317A1 (en) | Ifn receptors recognition factors, protein sequences and methods of use thereof | |
| Graw et al. | Genomic sequences of murine γB-and γC-crystallm-encoding genes: promoter analysis and complete evolutionary pattern of mouse, rat and human γ-crystallins | |
| US7060682B2 (en) | Receptor recognition factors, protein sequences and methods of use thereof | |
| Rodriguez et al. | NAP‐2 is part of multi‐protein complexes in Hela cells | |
| US6403299B1 (en) | DEAH-box proteins | |
| CN121347805B (zh) | 靶向sting-pdzd8相互作用蛋白的药物筛选系统及其应用 |